Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro

蜱唾液蛋白组分通过降低细胞活力和促进细胞凋亡来抑制乳腺癌的体外生长

阅读:1

Abstract

Tick saliva contains protein and non-protein bioactive molecules with potential therapeutic applications, including anticancer properties. In this study, the effects of protein and non-protein fractions of saliva from different tick species (Amblyomma spp. and Rhipicephalus sanguineus) at various concentrations (0.1-10 µg/mL) were tested on the viability, apoptosis, and necrosis of epithelial MDA-MB-231 breast cancer cells and spontaneously immortalized HaCaT cell control. Chemical composition of tick saliva from A. parvum and A. sculptum was characterized by proteomics analysis. Cell viability was assessed using a calcein-based fluorescence method. Hoechst staining quantified the total number of cells per well, while apoptosis and necrosis were evaluated using Hoescht and propidium iodide assays, respectively. On MDA-MB-231 cancer cells, the protein fraction from A. parvum and R. sanguineus significantly reduced cell viability at the highest concentration (10 µg/mL), whereas A. sculptum and non-protein fractions showed no significant effect. Hoechst staining revealed a significant reduction in cell attachment at 10 µg/mL for A. parvum and R. sanguineus. A modest apoptosis (3-8%) was induced by the protein fractions at concentrations as low as 0.1 µg/mL for R. sanguineus and 10 µg/mL for the non-protein fraction of A. sculptum. Necrosis was not observed, except for a slight increase (1%) with the protein fraction of R. sanguineus at 10 µg/mL. No effect of A. americanum tick saliva protein and non-protein fractions was observed in HaCaT control cells. The results of highly represented proteins identified in Amblyomma spp. correlated with effect of tick saliva protein fraction on cancer cells, highlighting the potential anticancer properties of tick saliva protein fraction, which can induce apoptosis and inhibit cell attachment in breast cancer cells. These findings provide a basis for future studies of tick saliva components as novel therapeutic agents and identifying active biomolecules and mechanisms of action.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。